Summary

The global Single-use Bioprocessing market was valued at $6,953.0 million in 2020, and is projected to reach $38,843.8 million by 2030, registering a CAGR of 18.4% from 2021 to 2030.
Single-use bioprocessing technology consists of disposable products that assist in manufacturing biopharmaceutical products. This technology has been rapidly adopted by various biopharmaceutical companies in the recent past. These technologies are applied in monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and other applications. The key factors that drive the market growth include rise in the adoption of single-use technologies, low risk of product cross contamination, cost-effectiveness, and less floor space requirement.
The major factors that propel the growth of the single-use bioprocessing market are growth in demand for biopharmaceuticals, new markets emerging across the world, faster implementation, lower risk of product cross-contamination & lower costs, and lesser environmental impact of single-use bioprocessing technologies. Single-use technology is one of the prominent technologies in the area of manufacturing scale and is widely used in upstream pre-commercial biopharmaceutical manufacturing. The high adoption of these devices is mainly due to their speed and flexibility while maintaining total operating expenditure.
Moreover, high energy efficiency, less space required, low water usage, and less risk of contamination associated with the product are some more factors that propel the revenue growth of the market. Furthermore, automation in the single-use system led to the incorporation of big data-based machine learning, which may help boost product yield and achieve maximum productivity & efficiency in terms of process, and a mainstream approach by many biopharmaceutical manufacturers that fuel the single-use bioprocessing market.
Furthermore, according to the Food and Drug Administration (FDA), 17 biologics were approved in 2018, of which 12 were monoclonal antibodies (mAb), three pegylated enzymes, one protein, and one fusion protein. Therefore, the growth in number of biological approvals and patent expiry is expected to increase the biopharmaceuticals manufacturing process, ultimately helping to increase the use of single-use bioprocessing over the forecast period. In addition, partnerships between industries and academic institutions have witnessed a significant rise over the recent years.
The single-use bioprocessing market in this report is studied on the basis of product, application, method, end user, and region. On the basis of product, the market is divided into bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, media bags & containers, mixing systems, tubing assemblies, sampling systems, and others. By application, the market is fragmented into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and others. By method, the market is classified into filtration, storage, cell culture, mixing, and purification. On the basis of end user, the market is divided into biopharmaceutical manufacturers, life science R&D companies & academic research institutes, and contract research organizations & manufacturers. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Region wise, North America dominated the market in 2020, as there is an on-going trend of introducing novel single-use bioprocessing devices in developed economies such as the U.S. and Canada, and then unveiling it to the rest of the world. North America is known for its healthcare facilities and medical services. However, Asia-Pacific is expected to witness considerable market growth during the forecast period due to significant demand for bioprocess equipment including laboratory filtration systems and membrane-based microbial analysis among many others.
The major players operating in the global single-use bioprocessing market are 3M Company, Cesco Bioengineering Co. Ltd., Danaher Corporation, Eppendorf AG., Corning Inc., Getinge Group, Merck KGaA, PBS Biotech, Sartorius Stedim Biotech, and Thermo Fisher Scientific, Inc. These players adopted product launch, collaboration, and merger & acquisition as their key developmental strategies.
KEY BENEFITS FOR STAKEHOLDERS
• The report provides in-depth analysis of the global single-use bioprocessing market size along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
• A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global single-use bioprocessing market growth.
KEY MARKET SEGMENTS
#By Product
##Bioreactors
##Tangential-flow Filtration Devices
##Depth Filters
##Disposable Filter Cartridges
##Media Bags & Containers
##Mixing Systems
##Tubing Assemblies
##Sampling Systems
##Other Products
#By Method
##Filtration
##Storage
##Cell Culture
##Mixing
##Purification
#By Application
##Monoclonal Antibody Production
##Storage
##Vaccine Production
##Plant Cell Cultivation
##Patient Specific Cell Therapies
##Other Applications
#By End User
##Biopharmaceutical Manufacturers
##Life Science R&D Companies & Academic Research Institutes
##Contract Research Organizations & Manufacturers
#By Region
##North America
###U.S.
###Canada
###Mexico
##Europe
###Germany
###France
###UK
###Italy
###Spain
###Rest of Europe
##Asia-Pacific
###Japan
###China
###Australia
###India
###South Korea
###Rest of Asia-Pacific
##LAMEA
###Brazil
###Saudi Arabia
###South Africa
###Rest of LAMEA
List of key players profiled in the report
• 3M Company
• Cesco Bioengineering Co. Ltd.
• Danaher Corporation
• Eppendorf AG.
• Corning Inc.
• Getinge Group
• Merck KGaA
• PBS Biotech
• Sartorius Stedim Biotech
• Thermo Fisher Scientific, Inc.

ページTOPに戻る

Table of Contents

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Bioreactors
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Tangential-Flow Filtration Devices
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Depth Filters
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Disposable Filter Cartridges
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Media Bags And Containers
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Mixing Systems
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
4.8 Tubing Assemblies
4.8.1 Key market trends, growth factors and opportunities
4.8.2 Market size and forecast, by region
4.8.3 Market analysis by country
4.9 Sampling Systems
4.9.1 Key market trends, growth factors and opportunities
4.9.2 Market size and forecast, by region
4.9.3 Market analysis by country
5.0 Others
5.0.1 Key market trends, growth factors and opportunities
5.0.2 Market size and forecast, by region
5.0.3 Market analysis by country
CHAPTER 5: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Monoclonal Antibody Production
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Vaccine Production
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Plant Cell Cultivation
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Patient Specific Cell Therapies
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Others
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
CHAPTER 6: SINGLE-USE BIOPROCESSING MARKET, BY METHOD
6.1 Overview
6.1.1 Market size and forecast
6.2 Filtration
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Storage
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Cell Culture
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Mixing
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
6.6 Purification
6.6.1 Key market trends, growth factors and opportunities
6.6.2 Market size and forecast, by region
6.6.3 Market analysis by country
CHAPTER 7: SINGLE-USE BIOPROCESSING MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Biopharmaceutical Manufacturers
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Life Science R&D Companies & Academic Research
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Contract Research Organization & Manufacturers
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
CHAPTER 8: SINGLE-USE BIOPROCESSING MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Product
8.2.3 North America Market size and forecast, by Application
8.2.4 North America Market size and forecast, by Method
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Product
8.2.6.1.2 Market size and forecast, by Application
8.2.6.1.3 Market size and forecast, by Method
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Product
8.2.6.2.2 Market size and forecast, by Application
8.2.6.2.3 Market size and forecast, by Method
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Product
8.2.6.3.2 Market size and forecast, by Application
8.2.6.3.3 Market size and forecast, by Method
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Product
8.3.3 Europe Market size and forecast, by Application
8.3.4 Europe Market size and forecast, by Method
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Product
8.3.6.1.2 Market size and forecast, by Application
8.3.6.1.3 Market size and forecast, by Method
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Product
8.3.6.2.2 Market size and forecast, by Application
8.3.6.2.3 Market size and forecast, by Method
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 United Kingdom
8.3.6.3.1 Market size and forecast, by Product
8.3.6.3.2 Market size and forecast, by Application
8.3.6.3.3 Market size and forecast, by Method
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Product
8.3.6.4.2 Market size and forecast, by Application
8.3.6.4.3 Market size and forecast, by Method
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Product
8.3.6.5.2 Market size and forecast, by Application
8.3.6.5.3 Market size and forecast, by Method
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Product
8.3.6.6.2 Market size and forecast, by Application
8.3.6.6.3 Market size and forecast, by Method
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Product
8.4.3 Asia-Pacific Market size and forecast, by Application
8.4.4 Asia-Pacific Market size and forecast, by Method
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Product
8.4.6.1.2 Market size and forecast, by Application
8.4.6.1.3 Market size and forecast, by Method
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Product
8.4.6.2.2 Market size and forecast, by Application
8.4.6.2.3 Market size and forecast, by Method
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Product
8.4.6.3.2 Market size and forecast, by Application
8.4.6.3.3 Market size and forecast, by Method
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 Australia
8.4.6.4.1 Market size and forecast, by Product
8.4.6.4.2 Market size and forecast, by Application
8.4.6.4.3 Market size and forecast, by Method
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 Rest of Asia-Pacific
8.4.6.5.1 Market size and forecast, by Product
8.4.6.5.2 Market size and forecast, by Application
8.4.6.5.3 Market size and forecast, by Method
8.4.6.5.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Product
8.5.3 LAMEA Market size and forecast, by Application
8.5.4 LAMEA Market size and forecast, by Method
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Product
8.5.6.1.2 Market size and forecast, by Application
8.5.6.1.3 Market size and forecast, by Method
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 Argentina
8.5.6.2.1 Market size and forecast, by Product
8.5.6.2.2 Market size and forecast, by Application
8.5.6.2.3 Market size and forecast, by Method
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 Turkey
8.5.6.3.1 Market size and forecast, by Product
8.5.6.3.2 Market size and forecast, by Application
8.5.6.3.3 Market size and forecast, by Method
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 South Africa
8.5.6.4.1 Market size and forecast, by Product
8.5.6.4.2 Market size and forecast, by Application
8.5.6.4.3 Market size and forecast, by Method
8.5.6.4.4 Market size and forecast, by End User
8.5.6.5 Rest of LAMEA
8.5.6.5.1 Market size and forecast, by Product
8.5.6.5.2 Market size and forecast, by Application
8.5.6.5.3 Market size and forecast, by Method
8.5.6.5.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 3M Company
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Applikon Biotechnology 
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Cesco Bioengineering C0. Ltd.
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Danaher Corporation
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 eppendorf ag
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Merck Milipore
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 PBS
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Sartorius Stedim Biotech S.A
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Thermo Fisher Scienctific
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments


LIST OF TABLES
TABLE 1. GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 2. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR BIOREACTORS, BY REGION , 2020-2030,($MILLION)
TABLE 3. SINGLE-USE BIOPROCESSING MARKET BIOREACTORS BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR TANGENTIAL-FLOW FILTRATION DEVICES, BY REGION , 2020-2030,($MILLION)
TABLE 5. SINGLE-USE BIOPROCESSING MARKET TANGENTIAL-FLOW FILTRATION DEVICES BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR DEPTH FILTERS, BY REGION , 2020-2030,($MILLION)
TABLE 7. SINGLE-USE BIOPROCESSING MARKET DEPTH FILTERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR DISPOSABLE FILTER CARTRIDGES, BY REGION , 2020-2030,($MILLION)
TABLE 9. SINGLE-USE BIOPROCESSING MARKET DISPOSABLE FILTER CARTRIDGES BY COUNTRY, 2020-2030,($MILLION)
TABLE 10. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR MEDIA BAGS AND CONTAINERS, BY REGION , 2020-2030,($MILLION)
TABLE 11. SINGLE-USE BIOPROCESSING MARKET MEDIA BAGS AND CONTAINERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 12. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR MIXING SYSTEMS, BY REGION , 2020-2030,($MILLION)
TABLE 13. SINGLE-USE BIOPROCESSING MARKET MIXING SYSTEMS BY COUNTRY, 2020-2030,($MILLION)
TABLE 14. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR TUBING ASSEMBLIES, BY REGION , 2020-2030,($MILLION)
TABLE 15. SINGLE-USE BIOPROCESSING MARKET TUBING ASSEMBLIES BY COUNTRY, 2020-2030,($MILLION)
TABLE 16. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR SAMPLING SYSTEMS, BY REGION , 2020-2030,($MILLION)
TABLE 17. SINGLE-USE BIOPROCESSING MARKET SAMPLING SYSTEMS BY COUNTRY, 2020-2030,($MILLION)
TABLE 18. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 19. SINGLE-USE BIOPROCESSING MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 20. GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 21. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION , 2020-2030,($MILLION)
TABLE 22. SINGLE-USE BIOPROCESSING MARKET MONOCLONAL ANTIBODY PRODUCTION BY COUNTRY, 2020-2030,($MILLION)
TABLE 23. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR VACCINE PRODUCTION, BY REGION , 2020-2030,($MILLION)
TABLE 24. SINGLE-USE BIOPROCESSING MARKET VACCINE PRODUCTION BY COUNTRY, 2020-2030,($MILLION)
TABLE 25. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR PLANT CELL CULTIVATION, BY REGION , 2020-2030,($MILLION)
TABLE 26. SINGLE-USE BIOPROCESSING MARKET PLANT CELL CULTIVATION BY COUNTRY, 2020-2030,($MILLION)
TABLE 27. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR PATIENT SPECIFIC CELL THERAPIES, BY REGION , 2020-2030,($MILLION)
TABLE 28. SINGLE-USE BIOPROCESSING MARKET PATIENT SPECIFIC CELL THERAPIES BY COUNTRY, 2020-2030,($MILLION)
TABLE 29. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 30. SINGLE-USE BIOPROCESSING MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 31. GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY METHOD, 2020-2030,($MILLION)
TABLE 32. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR FILTRATION, BY REGION , 2020-2030,($MILLION)
TABLE 33. SINGLE-USE BIOPROCESSING MARKET FILTRATION BY COUNTRY, 2020-2030,($MILLION)
TABLE 34. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR STORAGE, BY REGION , 2020-2030,($MILLION)
TABLE 35. SINGLE-USE BIOPROCESSING MARKET STORAGE BY COUNTRY, 2020-2030,($MILLION)
TABLE 36. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR CELL CULTURE, BY REGION , 2020-2030,($MILLION)
TABLE 37. SINGLE-USE BIOPROCESSING MARKET CELL CULTURE BY COUNTRY, 2020-2030,($MILLION)
TABLE 38. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR MIXING, BY REGION , 2020-2030,($MILLION)
TABLE 39. SINGLE-USE BIOPROCESSING MARKET MIXING BY COUNTRY, 2020-2030,($MILLION)
TABLE 40. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR PURIFICATION, BY REGION , 2020-2030,($MILLION)
TABLE 41. SINGLE-USE BIOPROCESSING MARKET PURIFICATION BY COUNTRY, 2020-2030,($MILLION)
TABLE 42. GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 43. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR BIOPHARMACEUTICAL MANUFACTURERS, BY REGION , 2020-2030,($MILLION)
TABLE 44. SINGLE-USE BIOPROCESSING MARKET BIOPHARMACEUTICAL MANUFACTURERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 45. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR LIFE SCIENCE R&D COMPANIES & ACADEMIC RESEARCH, BY REGION , 2020-2030,($MILLION)
TABLE 46. SINGLE-USE BIOPROCESSING MARKET LIFE SCIENCE R&D COMPANIES & ACADEMIC RESEARCH BY COUNTRY, 2020-2030,($MILLION)
TABLE 47. SINGLE-USE BIOPROCESSING MARKET REVENUE, FOR CONTRACT RESEARCH ORGANIZATION & MANUFACTURERS, BY REGION , 2020-2030,($MILLION)
TABLE 48. SINGLE-USE BIOPROCESSING MARKET CONTRACT RESEARCH ORGANIZATION & MANUFACTURERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 49. SINGLE-USE BIOPROCESSING MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 50. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 51. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 52. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET, BY METHOD, 2020-2030,($MILLION)
TABLE 53. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 54. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 55. U.S. SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 56. U.S. SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 57. U.S. SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 58. U.S. SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 59. CANADA SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 60. CANADA SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 61. CANADA SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 62. CANADA SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 63. MEXICO SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 64. MEXICO SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 65. MEXICO SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 66. MEXICO SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 67. EUROPE SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 68. EUROPE SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 69. EUROPE SINGLE-USE BIOPROCESSING MARKET, BY METHOD, 2020-2030,($MILLION)
TABLE 70. EUROPE SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 71. EUROPE SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 72. GERMANY SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 73. GERMANY SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 74. GERMANY SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 75. GERMANY SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 76. FRANCE SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 77. FRANCE SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 78. FRANCE SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 79. FRANCE SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 80. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 81. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 82. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 83. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 84. ITALY SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 85. ITALY SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 86. ITALY SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 87. ITALY SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 88. SPAIN SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 89. SPAIN SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 90. SPAIN SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 91. SPAIN SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 92. REST OF EUROPE SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 93. REST OF EUROPE SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 94. REST OF EUROPE SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 95. REST OF EUROPE SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 96. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 97. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 98. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET, BY METHOD, 2020-2030,($MILLION)
TABLE 99. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 100. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 101. JAPAN SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 102. JAPAN SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 103. JAPAN SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 104. JAPAN SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 105. CHINA SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 106. CHINA SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 107. CHINA SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 108. CHINA SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 109. INDIA SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 110. INDIA SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 111. INDIA SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 112. INDIA SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 113. AUSTRALIA SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 114. AUSTRALIA SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 115. AUSTRALIA SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 116. AUSTRALIA SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 117. REST OF ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 118. REST OF ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 119. REST OF ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 120. REST OF ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 121. LAMEA SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 122. LAMEA SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 123. LAMEA SINGLE-USE BIOPROCESSING MARKET, BY METHOD, 2020-2030,($MILLION)
TABLE 124. LAMEA SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 125. LAMEA SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 126. BRAZIL SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 127. BRAZIL SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 128. BRAZIL SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 129. BRAZIL SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 130. ARGENTINA SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 131. ARGENTINA SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 132. ARGENTINA SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 133. ARGENTINA SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 134. TURKEY SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 135. TURKEY SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 136. TURKEY SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 137. TURKEY SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 138. SOUTH AFRICA SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 139. SOUTH AFRICA SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 140. SOUTH AFRICA SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 141. SOUTH AFRICA SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 142. REST OF LAMEA SINGLE-USE BIOPROCESSING MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 143. REST OF LAMEA SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 144. REST OF LAMEA SINGLE-USE BIOPROCESSING MARKET BY METHOD 2020-2030,($MILLION)
TABLE 145. REST OF LAMEA SINGLE-USE BIOPROCESSING MARKET BY END USER 2020-2030,($MILLION)
TABLE 146.3M COMPANY: COMPANY SNAPSHOT
TABLE 147.3M COMPANY: OPERATING SEGMENTS
TABLE 148.3M COMPANY: PRODUCT PORTFOLIO
TABLE 149.3M COMPANY: NET SALES,
TABLE 150.3M COMPANY: KEY STRATERGIES
TABLE 151.APPLIKON BIOTECHNOLOGY : COMPANY SNAPSHOT
TABLE 152.APPLIKON BIOTECHNOLOGY : OPERATING SEGMENTS
TABLE 153.APPLIKON BIOTECHNOLOGY : PRODUCT PORTFOLIO
TABLE 154.APPLIKON BIOTECHNOLOGY : NET SALES,
TABLE 155.APPLIKON BIOTECHNOLOGY : KEY STRATERGIES
TABLE 156.CESCO BIOENGINEERING C0. LTD.: COMPANY SNAPSHOT
TABLE 157.CESCO BIOENGINEERING C0. LTD.: OPERATING SEGMENTS
TABLE 158.CESCO BIOENGINEERING C0. LTD.: PRODUCT PORTFOLIO
TABLE 159.CESCO BIOENGINEERING C0. LTD.: NET SALES,
TABLE 160.CESCO BIOENGINEERING C0. LTD.: KEY STRATERGIES
TABLE 161.DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 162.DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 163.DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 164.DANAHER CORPORATION: NET SALES,
TABLE 165.DANAHER CORPORATION: KEY STRATERGIES
TABLE 166.EPPENDORF AG: COMPANY SNAPSHOT
TABLE 167.EPPENDORF AG: OPERATING SEGMENTS
TABLE 168.EPPENDORF AG: PRODUCT PORTFOLIO
TABLE 169.EPPENDORF AG: NET SALES,
TABLE 170.EPPENDORF AG: KEY STRATERGIES
TABLE 171.MERCK MILIPORE: COMPANY SNAPSHOT
TABLE 172.MERCK MILIPORE: OPERATING SEGMENTS
TABLE 173.MERCK MILIPORE: PRODUCT PORTFOLIO
TABLE 174.MERCK MILIPORE: NET SALES,
TABLE 175.MERCK MILIPORE: KEY STRATERGIES
TABLE 176.PBS: COMPANY SNAPSHOT
TABLE 177.PBS: OPERATING SEGMENTS
TABLE 178.PBS: PRODUCT PORTFOLIO
TABLE 179.PBS: NET SALES,
TABLE 180.PBS: KEY STRATERGIES
TABLE 181.SARTORIUS STEDIM BIOTECH S.A: COMPANY SNAPSHOT
TABLE 182.SARTORIUS STEDIM BIOTECH S.A: OPERATING SEGMENTS
TABLE 183.SARTORIUS STEDIM BIOTECH S.A: PRODUCT PORTFOLIO
TABLE 184.SARTORIUS STEDIM BIOTECH S.A: NET SALES,
TABLE 185.SARTORIUS STEDIM BIOTECH S.A: KEY STRATERGIES
TABLE 186.THERMO FISHER SCIENCTIFIC: COMPANY SNAPSHOT
TABLE 187.THERMO FISHER SCIENCTIFIC: OPERATING SEGMENTS
TABLE 188.THERMO FISHER SCIENCTIFIC: PRODUCT PORTFOLIO
TABLE 189.THERMO FISHER SCIENCTIFIC: NET SALES,
TABLE 190.THERMO FISHER SCIENCTIFIC: KEY STRATERGIES


LIST OF FIGURES
FIGURE 1.SINGLE-USE BIOPROCESSING MARKET SEGMENTATION
FIGURE 2.SINGLE-USE BIOPROCESSING MARKET,2020-2030
FIGURE 3.SINGLE-USE BIOPROCESSING MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.SINGLE-USE BIOPROCESSING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.SINGLE-USE BIOPROCESSING MARKET,BY PRODUCT,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF BIOREACTORS SINGLE-USE BIOPROCESSING MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF TANGENTIAL-FLOW FILTRATION DEVICES SINGLE-USE BIOPROCESSING MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DEPTH FILTERS SINGLE-USE BIOPROCESSING MARKET,2020-2030(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF DISPOSABLE FILTER CARTRIDGES SINGLE-USE BIOPROCESSING MARKET,2020-2030(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF MEDIA BAGS AND CONTAINERS SINGLE-USE BIOPROCESSING MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MIXING SYSTEMS SINGLE-USE BIOPROCESSING MARKET,2020-2030(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF TUBING ASSEMBLIES SINGLE-USE BIOPROCESSING MARKET,2020-2030(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF SAMPLING SYSTEMS SINGLE-USE BIOPROCESSING MARKET,2020-2030(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHERS SINGLE-USE BIOPROCESSING MARKET,2020-2030(%)
FIGURE 21.SINGLE-USE BIOPROCESSING MARKET,BY APPLICATION,2020(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF MONOCLONAL ANTIBODY PRODUCTION SINGLE-USE BIOPROCESSING MARKET,2020-2030(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF VACCINE PRODUCTION SINGLE-USE BIOPROCESSING MARKET,2020-2030(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF PLANT CELL CULTIVATION SINGLE-USE BIOPROCESSING MARKET,2020-2030(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF PATIENT SPECIFIC CELL THERAPIES SINGLE-USE BIOPROCESSING MARKET,2020-2030(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF OTHERS SINGLE-USE BIOPROCESSING MARKET,2020-2030(%)
FIGURE 27.SINGLE-USE BIOPROCESSING MARKET,BY METHOD,2020(%)
FIGURE 28.COMPARATIVE SHARE ANALYSIS OF FILTRATION SINGLE-USE BIOPROCESSING MARKET,2020-2030(%)
FIGURE 29.COMPARATIVE SHARE ANALYSIS OF STORAGE SINGLE-USE BIOPROCESSING MARKET,2020-2030(%)
FIGURE 30.COMPARATIVE SHARE ANALYSIS OF CELL CULTURE SINGLE-USE BIOPROCESSING MARKET,2020-2030(%)
FIGURE 31.COMPARATIVE